BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 18675851)

  • 1. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
    Moraes CL; Bertoglio LJ; Carobrez AP
    Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of 5-HT receptors in the periaqueductal gray attenuates the tachycardia evoked from dorsomedial hypothalamus.
    Villela DC; da Silva LG; Fontes MA
    Auton Neurosci; 2009 Jun; 148(1-2):36-43. PubMed ID: 19303372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze.
    de Paula Soares V; Zangrossi H
    Brain Res Bull; 2004 Aug; 64(2):181-8. PubMed ID: 15342106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 5-HT2 and 5-HT1A receptors in the periaqueductal gray matter differentially modulate tonic immobility in guinea pig.
    Monassi CR; Menescal-de-Oliveira L
    Brain Res; 2004 May; 1009(1-2):169-80. PubMed ID: 15120594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
    Baptista D; Nunes-de-Souza RL; Canto-de-Souza A
    Behav Brain Res; 2012 Nov; 235(1):42-7. PubMed ID: 22800924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
    Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus.
    Dos Santos L; de Andrade TG; Zangrossi Junior H
    Eur Neuropsychopharmacol; 2008 Apr; 18(4):286-94. PubMed ID: 17728111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
    Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of median raphe nucleus 5-HT1A receptors in the regulation of generalized anxiety-related defensive behaviours in rats.
    Vicente MA; Zangrossi H; dos Santos L; de Macedo CE; Andrade TG
    Neurosci Lett; 2008 Nov; 445(3):204-8. PubMed ID: 18789373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures.
    Madhavan L; Freed WJ; Anantharam V; Kanthasamy AG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):913-23. PubMed ID: 12604665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT(1A) and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning.
    Elvander-Tottie E; Eriksson TM; Sandin J; Ogren SO
    Hippocampus; 2009 Dec; 19(12):1187-98. PubMed ID: 19309036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of interaction between NMDA and cholecystokinin-2 receptor-mediated neurotransmission in the dorsolateral periaqueductal gray in the regulation of rat defensive behaviors.
    Bertoglio LJ; Guimarães FS; Zangrossi H
    Life Sci; 2006 Nov; 79(23):2238-44. PubMed ID: 16914165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats.
    de Paula Soares V; Zangrossi H
    Behav Brain Res; 2009 Jan; 197(1):178-85. PubMed ID: 18801389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze.
    Zanoveli JM; Nogueira RL; Zangrossi H
    Eur J Pharmacol; 2003 Jul; 473(2-3):153-61. PubMed ID: 12892833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A receptors of the lateral septum regulate inhibitory avoidance but not escape behavior in rats.
    Viana Mde B; Zangrossi H; Onusic GM
    Pharmacol Biochem Behav; 2008 May; 89(3):360-6. PubMed ID: 18282594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
    Carli M; Balducci C; Samanin R
    Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
    Kincheski GC; Carobrez AP
    Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats.
    Santos P; Bittencourt AS; Schenberg LC; Carobrez AP
    Neuropharmacology; 2006 Aug; 51(2):203-12. PubMed ID: 16697017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.
    Bubeníková-Valesová V; Votava M; Pálenícek T; Horácek J
    Neuropharmacology; 2007 Mar; 52(4):1071-8. PubMed ID: 17196227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.